Annie Parker Foundation

Paxman has been pioneering scalp cooling technology for more than 20 years. They are proud to be the leading global experts in scalp cooling. The Paxman Scalp Cooling System is globally recognized as the leading product for hair-loss prevention during chemotherapy treatment.

The NCCN Guidelines now recommend scalp cooling as a category 2A treatment option for patients with invasive breast cancer The National Comprehensive Cancer Network® (NCCN®) has updated the Clinical Practice Guidelines in oncology for breast cancer (Version 1.2019) to include scalp cooling as a Category 2A recommendation to reduce the incidence of chemotherapy-induced alopecia for patients receiving chemotherapy.

Here’s a link to Paxman Introduction